Upcoming Catalysts Make BioCryst Pharmaceuticals a Stock to Watch Out for!
Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) are rallying after a discussion in r/wallstreetbets called it the “most undervalued stock in the market.” In January 2021, the Company had reported the grant of a marketing and manufacturing approval for oral, once-daily ORLADEYO™ (berotralstat) 150 mg for...
